EUVIMED · CrossrefJournal
Nucleic Acid Insights
ISSN 2977-4063 · BioInsights Publishing, Ltd.
Latest articles
Fireside chat: AI’s emerging role in oligonucleotide development and manufacturing
AI across the RNA therapeutics lifecycle: discovery, development, and the road to personalized medicine
Event preview of the RNA Leaders APAC Congress
Ongoing efforts to enhance stability
What do we actually mean by stability? A two-stage framework for mRNA–LNP development
Hybrid RNA/DNA origami nanostructures
Polymeric drug delivery systems for long‑acting and injectable therapeutics: structure–property relationships, mechanisms, and translational consideration
Challenges and advances for metabolically stabilizing siRNA
A mechanistic perspective of RNA‑LNP instability and characterization toolbox
Enhancing the Efficiency and Sustainability of Oligonucleotide Manufacturing
Industry insights: Clinical advances and regulatory momentum across nucleic acid therapeutic modalities
From UltraCold to ambient: what’s actually working for mRNA/saRNA stability
Downstream processing of oligonucleotides: meeting regulatory and commercial demands
Harnessing analytical tool innovation for R&D, product characterization, and QC
Analytical perspectives on novel oligonucleotide modalities
Considerations for chromatographic and mass spectrometry analytical methods for complex oligonucleotide therapeutic analysis
Event preview of the 6th mRNA‑Based Therapeutics Summit
Industry Insights: Advancing oligonucleotide therapeutics through regulatory approvals, clinical data, and AI-enabled discovery
Fireside chat: advancing analytical science and regulatory readiness for nucleic acid medicines
Polypeptide nanoparticles: a clinically validated, versatile delivery platform for RNA therapeutics
Exploring the future of nucleic acid therapeutics: expert perspectives from the Nucleic Acid Insights Editorial Advisory Board
Under the radar in siRNA therapeutics
Decoding mRNA stability: from endogenous decay pathways to therapeutic design
Selective removal of immunogenic double-stranded RNA from mRNA feeds using affinity chromatography
Programmable RNA therapeutics: from intracellular sensing to cell-specific delivery
Targeting mRNA therapeutics: current approaches and emerging platforms
Case studies: Advancing bioprocess analytics with Slope Spectroscopy
Industry Insights: Regulatory progress and AI-driven advances in nucleic acid therapeutics
Targeting mRNA therapeutics: current approaches and emerging platforms
Event preview of TIDES USA 2026
EUVIMED